Antitumor Effect of Sorafenib and mTOR Inhibitor in Liver Transplantation Recipients With Hepatocellular Carcinoma Recurrence
Liver Transplantation - United States
doi 10.1002/lt.25191
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Wiley